Persistent Covid-19: possible blood biomarkers identified for diagnosis

Persistent Covid-19: possible blood biomarkers identified for diagnosis

Analysis of blood samples from patients with Covid-19 persistent, a debilitating condition of unknown causeshas revealed changes in serum proteins as the probable cause, a finding that could offer potential biomarkers for diagnosis and information about treatment.

Not all patients fully recover from Covid-19; Approximately 20% of people diagnosed with this disease and about 5% of all people infected with SARS-CoV-2 develop persistent symptoms, which can last for many months.

Symptoms can include fatigue, discomfort after exertion and cognitive inability, in addition to involving multiple organs, recalls a summary of the magazine.

Although previous studies have shown that patients with long Covid-19 present signs of immune dysfunction, persistent activation of immune cells and production of autoimmune antibodies, the underlying cause is still not well understood and the diagnostic biomarkers for this condition are not properly defined.

Currently, persistent Covid-19 also does not have an effective treatment.

In this research, the team from the University of Zurich reports the findings of a longitudinal analysis of the blood serum of 113 patients (at six months, 40 of them had active persistent Covid), and compared the results with healthy controls (39 people).

Using high-throughput proteomics – protein structure and function – approaches, the researchers measured serum levels of 6,596 proteins among the participants.

Subjects with confirmed acute covid were followed up for up to a year and new samples were taken at 6 and 12 months. According to the results, patients had a greater amount of proteins related to complement activation, a system related to the inflammatory and immune response.

“In patients with persistent covid, the complement system no longer returns to its basal state, but remains activated and, therefore, also damages healthy cells in the body,” says scientist Onur Boyman in a statement from the University of Zurich.

Besides, researchers found increased antibodies against cytomegalovirus and Epstein-Barr virus; This could drive activation of the complement system, which can lead to tissue damage.

Study findings identify potential biomarkers for persistent Covid-19 and open the door to new treatment strategies that justify additional research in both the diagnostic and therapeutic fields, the authors summarize in their article, for which they also used machine learning.

“Our work not only lays the foundation for improving diagnosis, but also supports clinical research into substances that could be used to regulate the complement system. This opens new avenues for the development of more specific therapies for patients with persistent covid,” summarizes Boyman.

David Lynn, professor of Systems Immunology at Flinders University in Australia, who is not involved in the research, calls the findings exciting and important.

However, he adds, This publication is one of several high-profile publications known in the last year or two showing that different aspects of the immune system are dysregulated in long covid.

“There is a lot of work to be done to unify the different mechanisms that have been proposed in these different studies and, more importantly, to develop novel treatments based on these findings,” says the scientist in statements provided by Science Media Centre, a scientific resource platform for journalists.

Kumneger Media
Kumneger Media
Kumneger Media is a News and Entertainment Website & Channel. Kumneger Media in addition to News and Entertainment it is the hub of Politics, Movies, Drama, Music, Comedy, Documentary and More!